BridgeMD
New treatment option for Neuropathy, Facial
Official title Different Laser Frequencies on Neuropathic Outcomes in Patients With Bell's Palsy
ClinicalTrials.gov ID: NCT07519421
What this study is testing
- What it's testing
- this study was done to compare different laser frequencies on neuropathic outcomes in patients with Bell's palsy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Eighty people from both genders diagnosed with Bell's palsy will be recruited through direct referrals from their independent physician's neurology...
- people aged 18 and above from all genders
- Unilateral Bell's palsy either on the right or left side.
- The Facial disability index will be used for assessment and progression of Bell's palsy before and after treatment protocol.
- Patients will on level II, III, IV and V of House-Brackmann scale.
You likely can't join if
- We will exclude patients who had central nervous system pathology, sensory loss over the face, or recurrence of facial palsy.
- Upper motor neuron fascial nerve palsy.
- Any infant or child (\<18 years).
- Bilateral Facial nerve palsy
- Severe hypertension (Blood pressure more than 200/120 mmHg).
The study team makes the final eligibility decision.
Where it's taking place
- Madinah, Saudi Arabia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madinah, Saudi Arabia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.